GLP-1 Receptor Agonist Repurposing Across Indications: Mechanism, Evidence and Trial Sequencing. Translational Medicine & Therapeutics Journal, [S. l.], v. 4, n. 1, p. 10–18, 2025. DOI: 10.5281/zenodo.22649327. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/104. Acesso em: 5 nov. 2026.